GSK refutes consumer spin-off rumor

GlaxoSmithKline is not looking to offload its consumer business. Bloomberg reports that the UK drugmaker refuted a Financial Times article that indicated a spin-off was imminent.

This does not mean it could not happen—GSK  tells Bloomberg it won't turn the consumer business into a free-standing operation “in the near term.”

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.